Product Program year 2025 Source: CMS Open Payments

Nxstage Pureflow Solution

Device Nephrology

PDI M535RFP2040

Open in the dashboard

General payments

$10,314

191 payments

Research payments

$0

0 payments

Through program year 2025, $10,314 in general payments and $0 in research payments were reported against Nxstage Pureflow Solution (Nephrology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $4,715 84
2024 General $1,188 26
2023 General $2,305 42
2022 General $1,371 18
2021 General $735 21

Breakdown

Who paid General payments · program years 2021–2025
  1. NxStage Medical, Inc. $10,156 188 payments
  2. Fresenius USA Marketing, Inc. $158 3 payments
Top recipients General payments · program year 2025
  1. Lance Dicker Nephrology · Salem, OR $225 5% · 3 payments
  2. Kumar Rohit Salem, OR $205 4% · 3 payments
  3. Mark Anthony Cabrera Nephrology · Spokane, WA $143 3% · 2 payments
  4. Katy Hernandez Nurse Practitioner · Salem, OR $143 3% · 2 payments
  5. Zain Haq Nephrology · Corvallis, OR $143 3% · 2 payments

The top 5 of 69 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Nephrology Internal Medicine $2,499 61% · 39 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $400 10% · 4 practitioners
  3. Internal Medicine $329 8% · 7 practitioners
  4. Nurse Practitioner $312 8% · 5 practitioners
  5. Physician Assistant, Medical Physician Assistant $143 3% · 1 practitioner

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Oregon $1,622 34% · 19 recipients
  2. Hawaii $656 14% · 5 recipients
  3. Texas $448 9% · 6 recipients
  4. West Virginia $410 9% · 5 recipients
  5. Georgia $395 8% · 7 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

191 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record